[Ru(bpy)2(5-cyanouracil)2]2+ As a Potential Light-activated Dual-action Therapeutic Agent

Overview

Journal Inorg Chem

Specialty Chemistry

Date 2011 Sep 2

PMID 21879748

Citations 44

Authors

Robert N Garner

Judith C Gallucci

Kim R Dunbar

Claudia Turro

Affiliations

Soon will be listed here.

Abstract

The cation cis-[Ru(bpy)(2)(5CNU)(2)](2+) (bpy = 2,2'-bipyridine; 5CNU = 5-cyanouracil) was synthesized and investigated for use as a potential light-activated dual-action therapeutic agent. The complex undergoes efficient photoinduced 5CNU ligand exchange for solvent water molecules, thus simultaneously releasing biologically active 5CNU and generating [Ru(bpy)(2)(H(2)O)(2)](2+). The latter binds covalently to ds-DNA, such that photolysis results in the generation of 3 equiv of potential therapeutic agents from a single molecule.

Citing Articles

An Increase in the Rigidity of the Environment Favors MLCT over the MC State in [Ru(bpy)(Nicotine)](Cl): A Case Study of Photolabile Ligands.

Semwal M, Vashistha N, Rau S, Dietzek-Ivansic B J Phys Chem A. 2024; 129(2):439-446.

PMID: 39496280 PMC: 11744796. DOI: 10.1021/acs.jpca.4c04914.

Light Activated Release of Nitrile Ligands from -Ru(L)(PPh)(nitrile) Complexes.

Davidson R, Hsu Y, Yufit D, Beeby A ACS Omega. 2024; 9(31):34098-34105.

PMID: 39130607 PMC: 11307298. DOI: 10.1021/acsomega.4c04917.

Binding of Stimuli-Responsive Ruthenium Aqua Complexes with 9-Ethylguanine.

Maeda A, Tokumoto J, Kojima S, Fujimori K, Moriuchi-Kawakami T, Hirahara M ACS Omega. 2023; 8(40):37391-37401.

PMID: 37841177 PMC: 10569010. DOI: 10.1021/acsomega.3c05343.

Ligand Rigidity Steers the Selectivity and Efficiency of the Photosubstitution Reaction of Strained Ruthenium Polypyridyl Complexes.

Hakkennes M, Meijer M, Menzel J, Goetz A, Van Duijn R, Siegler M J Am Chem Soc. 2023; 145(24):13420-13434.

PMID: 37294954 PMC: 10299800. DOI: 10.1021/jacs.3c03543.

Photosubstitution in a trisheteroleptic ruthenium complex inhibits conjunctival melanoma growth in a zebrafish orthotopic xenograft model.

Chen Q, Cuello-Garibo J, Bretin L, Zhang L, Ramu V, Aydar Y Chem Sci. 2022; 13(23):6899-6919.

PMID: 35774173 PMC: 9200134. DOI: 10.1039/d2sc01646j.

References

Higgins S, White T, Winkel B, Brewer K . Redox, spectroscopic, and photophysical properties of Ru-Pt mixed-metal complexes incorporating 4,7-diphenyl-1,10-phenanthroline as efficient DNA binding and photocleaving agents. Inorg Chem. 2010; 50(2):463-70. DOI: 10.1021/ic100958r. View

Liu Y, Hammitt R, Lutterman D, Joyce L, Thummel R, Turro C . Ru(II) complexes of new tridentate ligands: unexpected high yield of sensitized 1O2. Inorg Chem. 2008; 48(1):375-85. DOI: 10.1021/ic801636u. View

Liu Y, Turner D, Singh T, Angeles-Boza A, Chouai A, Dunbar K . Ultrafast ligand exchange: detection of a pentacoordinate Ru(II) intermediate and product formation. J Am Chem Soc. 2008; 131(1):26-7. DOI: 10.1021/ja806860w. View

Liu H, Sadler P . Metal complexes as DNA intercalators. Acc Chem Res. 2011; 44(5):349-59. DOI: 10.1021/ar100140e. View

Jain A, Wang J, Mashack E, Winkel B, Brewer K . Multifunctional DNA interactions of Ru-Pt mixed metal supramolecular complexes with substituted terpyridine ligands. Inorg Chem. 2009; 48(19):9077-84. DOI: 10.1021/ic900190a. View

Ronconi L, Sadler P . Photoreaction pathways for the anticancer complex trans,trans,trans-[Pt(N3)2(OH)2(NH3)2]. Dalton Trans. 2010; 40(1):262-8. DOI: 10.1039/c0dt00546k. View

Zhao R, Hammitt R, Thummel R, Liu Y, Turro C, Snapka R . Nuclear targets of photodynamic tridentate ruthenium complexes. Dalton Trans. 2009; (48):10926-31. DOI: 10.1039/b913959a. View

Antonarakis E, Emadi A . Ruthenium-based chemotherapeutics: are they ready for prime time?. Cancer Chemother Pharmacol. 2010; 66(1):1-9. PMC: 4020437. DOI: 10.1007/s00280-010-1293-1. View

Farrer N, Woods J, Munk V, Mackay F, Sadler P . Photocytotoxic trans-diam(m)ine platinum(IV) diazido complexes more potent than their cis isomers. Chem Res Toxicol. 2009; 23(2):413-21. PMC: 2933822. DOI: 10.1021/tx900372p. View

10.

Aguirre J, Angeles-Boza A, Chouai A, Pellois J, Turro C, Dunbar K . Live cell cytotoxicity studies: documentation of the interactions of antitumor active dirhodium compounds with nuclear DNA. J Am Chem Soc. 2009; 131(32):11353-60. DOI: 10.1021/ja9021717. View

11.

Porter D, Chestnut W, Merrill B, Spector T . Mechanism-based inactivation of dihydropyrimidine dehydrogenase by 5-ethynyluracil. J Biol Chem. 1992; 267(8):5236-42. View

12.

Gentry G, Morse Jr P, Dorsett M . In vivo inhibition of pyrimidine catabolism by 5-cyanouracil. Cancer Res. 1971; 31(6):909-12. View

13.

Farrer N, Salassa L, Sadler P . Photoactivated chemotherapy (PACT): the potential of excited-state d-block metals in medicine. Dalton Trans. 2009; (48):10690-701. PMC: 2933824. DOI: 10.1039/b917753a. View

14.

Singh T, Turro C . Photoinitiated DNA Binding by cis-[Ru(bpy)2(NH3)2]2+. Inorg Chem. 2004; 43(23):7260-2. DOI: 10.1021/ic049075k. View

15.

Bradley P, Angeles-Boza A, Dunbar K, Turro C . Direct DNA photocleavage by a new intercalating dirhodium(II/II) complex: comparison to Rh2(mu-O2CCH3)4. Inorg Chem. 2004; 43(8):2450-2. DOI: 10.1021/ic035424j. View

16.

Angeles-Boza A, Bradley P, Fu P, Wicke S, Bacsa J, Dunbar K . DNA binding and photocleavage in vitro by new dirhodium(II) dppz complexes: correlation to cytotoxicity and photocytotoxicity. Inorg Chem. 2004; 43(26):8510-9. DOI: 10.1021/ic049091h. View

17.

Sun Y, Joyce L, Dickson N, Turro C . DNA photocleavage by an osmium(II) complex in the PDT window. Chem Commun (Camb). 2010; 46(36):6759-61. DOI: 10.1039/c0cc02571b. View

18.

Sun Y, Joyce L, Dickson N, Turro C . Efficient DNA photocleavage by [Ru(bpy)2(dppn)]2+ with visible light. Chem Commun (Camb). 2010; 46(14):2426-8. DOI: 10.1039/b925574e. View

19.

Lutterman D, Fu P, Turro C . cis-[Rh2(mu-O2CCH3)2(CH3CN)6]2+ as a photoactivated cisplatin analog. J Am Chem Soc. 2006; 128(3):738-9. DOI: 10.1021/ja057620q. View

20.

Longley D, Harkin D, Johnston P . 5-fluorouracil: mechanisms of action and clinical strategies. Nat Rev Cancer. 2003; 3(5):330-8. DOI: 10.1038/nrc1074. View